The global Irritable Bowel Syndrome (IBS) Treatment Market is experiencing significant growth and is expected to continue its upward trajectory in the coming years. Valued at USD 3.05 billion in 2023, the market is projected to reach USD 6.46 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2032. This growth is attributed to increasing awareness of IBS, an...